Moreover, AD patients and mice with AD-like dermatitis have increased IL-33 and ST2 levels10,13, and transgenic mice that selectively overexpress IL-33 in keratinocytes develop an AD-like disease14. The gene discussed is IL33; the disease is dermatitis.